IPO pipeline thaws
Five companies filed to go public Monday across sectors — filings include a convenience-store chain, an obesity biotech, a proteomics firm, a healthcare REIT and Bill Ackman’s Pershing Square vehicle that’s reportedly targeting up to $10 billion, with the other offerings totaling roughly $1.5 billion. Separately, filings show consumer brand Suja preparing an IPO and IRRX submitting an S‑1 to uplist to Nasdaq after a confidential draft. (x.com) (x.com) (x.com)
A burst of April filings suggests the United States initial public offering market is moving again after a stop-start stretch. (reuters.com) On Monday, April 13, Yesway, Kailera Therapeutics, Alamar Biosciences and National Healthcare Properties all launched roadshows or set terms for offerings, while Bill Ackman’s Pershing Square began marketing a combined listing of a new fund and management company. Reuters reported the group spans convenience stores, obesity drugs, proteomics and healthcare real estate. (reuters.com) Yesway said it expects to sell 13,953,488 Class A shares at $20 to $23 each, a deal that would raise about $300 million at the midpoint. The Fort Worth company operates convenience stores and truck stops across the United States. (prnewswire.com) Kailera set a range of $14 to $16 for 33.3 million shares, targeting about $500 million, and Alamar set a range of $15 to $17 for 9.4 million shares, targeting about $150 million. Kailera is developing injectable and oral glucagon-like peptide-1, or GLP-1, obesity drugs, while Alamar sells tools that detect tiny amounts of proteins for disease research. (renaissancecapital.com 1) (renaissancecapital.com 2) National Healthcare Properties set terms for 38.5 million shares at $13 to $16 each, which points to roughly $558 million in proceeds at the midpoint. The real estate investment trust said its portfolio included 37 senior housing communities and 130 outpatient medical facilities as of December 31, 2025. (renaissancecapital.com 1) (renaissancecapital.com 2) Pershing Square USA is the biggest piece of the week’s calendar. Bloomberg reported the closed-end fund could raise as much as $10 billion, and SEC materials say buyers in that offering would also receive shares in Pershing Square Inc., the management company. (bloomberg.com) (sec.gov) The filings arrive after a period when many companies stayed private longer and delayed listings during rate shocks and market volatility. Reuters said issuers are moving ahead even with markets still choppy, and Renaissance Capital’s calendar now shows a thicker lineup of April deals. (reuters.com) (renaissancecapital.com) The sector mix also stands out. Consumer staples, biotechnology, diagnostics, real estate and alternative asset management are all testing demand in the same week, which is a broader cross-section than the market saw during many of the thin issuance windows in 2024 and 2025. (reuters.com) (renaissancecapital.com) Two other names also moved into the pipeline days earlier. Suja Life publicly filed on April 10 after confidential submissions that began in November 2025, and Renaissance Capital said the cold-pressed juice and functional drinks company is seeking up to $100 million. (sec.gov) (renaissancecapital.com) Integrated Rail & Resources, which trades over the counter as IRRX, said in March that it had confidentially submitted a draft Form S-1 as part of a plan to become a listed company and had changed its name from Uinta Infrastructure Group. The company said at the time that the registration statement was not yet effective. (stocktitan.net) (advfn.com) What happens next is simpler than the filing rush: investors decide which of these stories deserve fresh capital. If the April deals price and hold up in trading, the backlog behind them gets shorter fast. (renaissancecapital.com) (reuters.com)
